76 related articles for article (PubMed ID: 38740918)
1. Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures.
Sui P; Liu X; Zhong C; Sha Z
Sci Rep; 2024 May; 14(1):10873. PubMed ID: 38740918
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
Koh YW; Han JH; Haam S; Lee HW
Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
[TBL] [Abstract][Full Text] [Related]
3. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q
BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma.
Liu Z; Lu Q; Zhang Z; Feng Q; Wang X
Respir Res; 2024 Jun; 25(1):238. PubMed ID: 38862975
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma.
Li R; Tong R; Zhang JL; Zhang Z; Deng M; Hou G
J Cancer Res Clin Oncol; 2024 May; 150(5):246. PubMed ID: 38722401
[TBL] [Abstract][Full Text] [Related]
6. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
7. A Novel Nucleic Acid Sensing-related Genes Signature for Predicting Immunotherapy Efficacy and Prognosis of Lung Adenocarcinoma.
Peng X; Wu H; Zhang B; Xu C; Lang J
Curr Cancer Drug Targets; 2024; 24(4):425-444. PubMed ID: 37592781
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses.
Liu Y; Zhang X; Pang Z; Wang Y; Zheng H; Wang G; Wang K; Du J
Aging (Albany NY); 2024 May; 16(10):8772-8809. PubMed ID: 38771130
[TBL] [Abstract][Full Text] [Related]
9. Construction of a prognostic model based on memory CD4+ T cell-associated genes for lung adenocarcinoma and its applications in immunotherapy.
Li Y; Ye X; Huang H; Cao R; Huang F; Chen L
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):837-852. PubMed ID: 38594917
[TBL] [Abstract][Full Text] [Related]
10. Proteomic, single-cell and bulk transcriptomic analysis of plasma and tumor tissues unveil core proteins in response to anti-PD-L1 immunotherapy in triple negative breast cancer.
Li Y; Yue L; Zhang S; Wang X; Zhu YN; Liu J; Ren H; Jiang W; Wang J; Zhang Z; Liu T
Comput Biol Med; 2024 Jun; 176():108537. PubMed ID: 38744008
[TBL] [Abstract][Full Text] [Related]
11. The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment.
Xu M; Li S
Cancer Lett; 2024 Jul; 593():216969. PubMed ID: 38768681
[TBL] [Abstract][Full Text] [Related]
12. Construction of an Anoikis-Related Gene Prognostic Signature and Identification of ANGPTL4 as a Key Oncogene in Lung Adenocarcinoma.
Lou H; Lin X; Wei G; Wu Z; Xiao Y
Mol Biotechnol; 2024 May; 66(5):1290-1302. PubMed ID: 38381376
[TBL] [Abstract][Full Text] [Related]
13. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data.
Gu Y; Bian C; Wang H; Fu C; Xue W; Zhang W; Mu G; Xia Y; Wei K; Wang J
Aging (Albany NY); 2024 May; 16(10):8822-8842. PubMed ID: 38771142
[TBL] [Abstract][Full Text] [Related]
15. Identifying and assessing a prognostic model based on disulfidptosis-related genes: implications for immune microenvironment and tumor biology in lung adenocarcinoma.
Wang J; Liu K; Li J; Zhang H; Gong X; Song X; Wei M; Hu Y; Li J
Front Immunol; 2024; 15():1371831. PubMed ID: 38840910
[TBL] [Abstract][Full Text] [Related]
16. Deciphering lung adenocarcinoma evolution: Integrative single-cell genomics identifies the prognostic lung progression associated signature.
Zhang P; Yang Z; Liu Z; Zhang G; Zhang L; Zhang Z; Fan J
J Cell Mol Med; 2024 Jun; 28(11):e18408. PubMed ID: 38837585
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based integration develops an immunogenic cell death-derived lncRNA signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
Sun J; Guo H; Zhang S; Nie Y; Zhou S; Zeng Y; Sun Y
Sci Rep; 2024 May; 14(1):11724. PubMed ID: 38778157
[TBL] [Abstract][Full Text] [Related]
18. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
Yang J; Liu Y; Geng Q; Wang B
Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
[TBL] [Abstract][Full Text] [Related]
19. Single-cell and single-nucleus RNA-sequencing from paired normal-adenocarcinoma lung samples provide both common and discordant biological insights.
Renaut S; Saavedra Armero V; Boudreau DK; Gaudreault N; Desmeules P; Thériault S; Mathieu P; Joubert P; Bossé Y
PLoS Genet; 2024 May; 20(5):e1011301. PubMed ID: 38814983
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic signature based on anoikis-related lncRNAs in lung adenocarcinoma.
Dong X; Shao C; Xu S; Tu J; Xu W; Chen D; Tang Y
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38850527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
